97 related articles for article (PubMed ID: 8823451)
1. Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation.
Espinosa MT; Fox R; Creger RJ; Lazarus HM
Transfusion; 1996 Sep; 36(9):789-93. PubMed ID: 8823451
[TBL] [Abstract][Full Text] [Related]
2. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
Webb IJ; Coral FS; Andersen JW; Elias AD; Finberg RW; Nadler LM; Ritz J; Anderson KC
Transfusion; 1996 Sep; 36(9):782-8. PubMed ID: 8823450
[TBL] [Abstract][Full Text] [Related]
3. In vitro collection and posttransfusion engraftment characteristics of MNCs obtained by using a new separator for autologous PBPC transplantation.
Snyder EL; Baril L; Cooper DL; Min K; Mechanic S; Stoddart L; Burtness B; Seagraves P; Debelak J; Gudino M; McCullough J
Transfusion; 2000 Aug; 40(8):961-7. PubMed ID: 10960524
[TBL] [Abstract][Full Text] [Related]
4. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.
Weaver CH; Schwartzberg L; Li W; Hazelton B; West W
Bone Marrow Transplant; 1996 May; 17(5):715-21. PubMed ID: 8733687
[TBL] [Abstract][Full Text] [Related]
6. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
7. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections.
Lazarus HM; Haynesworth SE; Gerson SL; Caplan AI
J Hematother; 1997 Oct; 6(5):447-55. PubMed ID: 9368181
[TBL] [Abstract][Full Text] [Related]
8. Bacterial contamination of peripheral blood progenitor cells for transplantation.
Jestice HK; Farrington M; Hunt C; Matthews I; Scott MA; Foreman J; Marcus RE
Transfus Med; 1996 Jun; 6(2):103-10. PubMed ID: 8809956
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
Shpall EJ; Jones RB; Bearman SI; Franklin WA; Archer PG; Curiel T; Bitter M; Claman HN; Stemmer SM; Purdy M
J Clin Oncol; 1994 Jan; 12(1):28-36. PubMed ID: 7505806
[TBL] [Abstract][Full Text] [Related]
10. The emergence of peripheral blood progenitor cells to support intensive chemotherapy for patients with breast cancer.
Demetri GD
Pharmacotherapy; 1996; 16(3 Pt 2):94S-100S. PubMed ID: 8726588
[TBL] [Abstract][Full Text] [Related]
11. Femoral vascular access for large-volume collection of peripheral blood progenitor cells.
Shariatmadar S; Noto TA
J Clin Apher; 1998; 13(3):99-102. PubMed ID: 9828018
[TBL] [Abstract][Full Text] [Related]
12. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.
Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H
Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984
[TBL] [Abstract][Full Text] [Related]
13. Multi-purpose silastic dual-lumen central venous catheters for both collection and transplantation of hematopoietic progenitor cells.
Lazarus HM; Trehan S; Miller R; Fox RM; Creger RJ; Raaf JH
Bone Marrow Transplant; 2000 Apr; 25(7):779-85. PubMed ID: 10745265
[TBL] [Abstract][Full Text] [Related]
14. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.
Koç ON; Gerson SL; Cooper BW; Dyhouse SM; Haynesworth SE; Caplan AI; Lazarus HM
J Clin Oncol; 2000 Jan; 18(2):307-16. PubMed ID: 10637244
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow.
Klein JL; Hamm C; Dansey RD; Karanes C; Abella E; Cassells L; Peters WP; Baynes RD
Bone Marrow Transplant; 2001 Dec; 28(11):1023-9. PubMed ID: 11781611
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
Moskowitz CH; Glassman JR; Wuest D; Maslak P; Reich L; Gucciardo A; Coady-Lyons N; Zelenetz AD; Nimer SD
Clin Cancer Res; 1998 Feb; 4(2):311-6. PubMed ID: 9516916
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two leukapheresis programs for computerized collection of blood progenitor cells on a new cell separator.
Schwella N; Movassaghi K; Scheding S; Ahrens N; Salama A
Transfusion; 2003 Jan; 43(1):58-64. PubMed ID: 12519431
[TBL] [Abstract][Full Text] [Related]
18. Microbial contamination of peripheral blood stem cell collections.
Attarian H; Bensinger WI; Buckner CD; McDonald DL; Rowley SD
Bone Marrow Transplant; 1996 May; 17(5):699-702. PubMed ID: 8733684
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells.
Beguin Y; Baudoux E; Sautois B; Fraipont V; Schaaf-Lafontaine N; Pereira M; Paulus JM; Sondag D; Fillet G
Transfusion; 1998 Feb; 38(2):199-208. PubMed ID: 9531955
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of peripheral blood progenitor cells with paclitaxel-based chemotherapy.
Shea TC
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-105-S2-107. PubMed ID: 9045326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]